Hepatic blood inflow occlusion without hemihepatic artery control in treatment of hepatocellular carcinoma

Table 1 Patients’ background information¹ (mean ± SD)

Groups	Pringle maneuver (n = 20)	HVO (n = 20)	BIOwHAC (n = 19)
Age (yr)	54.35 ± 10.03	54.20 ± 11.34	54.26 ± 7.05
Gender (M:F)	16:4	13:7	14:5
Pathologic diagnosis	HCC	HCC	HCC
Complication hepatocirrhosis (cases)	10	9	10
Hepatitis virus positive (cases)	18	18	17
Increase in AFP (cases)	12	11	10
Child’s disease grade (cases, A:B)	19:1	19:1	18:1
Serum albumin (g/L)	40.04 ± 3.42	40.87 ± 3.12	39.78 ± 2.71
Serum bilirubin (μmol/L)	12.86 ± 5.60	14.68 ± 3.37	13.08 ± 7.81
Serum ALT (U/L)	45.22 ± 32.99	45.04 ± 63.01	47.63 ± 40.48
Serum AST (U/L)	39.43 ± 17.20	40.72 ± 21.57	41.56 ± 41.01

¹There is no significant intergroup difference (P > 0.05). BIOwHAC: Hepatic blood inflow occlusion without hemihepatic artery control; HVO: Hemihepatic vascular occlusion; AFP: α-fetoprotein; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase.